tiprankstipranks
Soleno price target raised to $123 at Cantor Fitzgerald after VYKAT XR approved
PremiumThe FlySoleno price target raised to $123 at Cantor Fitzgerald after VYKAT XR approved
3d ago
Soleno Therapeutics price target raised to $102 from $72 at Baird
Premium
The Fly
Soleno Therapeutics price target raised to $102 from $72 at Baird
3d ago
Aardvark Therapeutics price target raised to $26 from $22 at BofA
Premium
The Fly
Aardvark Therapeutics price target raised to $26 from $22 at BofA
3d ago
Soleno Therapeutics trading resumes
PremiumThe FlySoleno Therapeutics trading resumes
3d ago
Soleno Therapeutics to resume trading at 6:45 pm ET
Premium
The Fly
Soleno Therapeutics to resume trading at 6:45 pm ET
3d ago
Soleno Therapeutics announces FDA approval of VYKATTM XR to treat hyperphagia
Premium
The Fly
Soleno Therapeutics announces FDA approval of VYKATTM XR to treat hyperphagia
3d ago
Soleno Therapeutics reports Q4 EPS ($1.27) vs. (33c) last year
PremiumThe FlySoleno Therapeutics reports Q4 EPS ($1.27) vs. (33c) last year
1M ago
Soleno Therapeutics Enhances Executive Compensation Structure
Premium
Company Announcements
Soleno Therapeutics Enhances Executive Compensation Structure
2M ago
Soleno Therapeutics weakness a buying opportunity, says Baird
Premium
The Fly
Soleno Therapeutics weakness a buying opportunity, says Baird
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100